SCHEMBL25530634

SCHEMBL25530634

CN1C(=O)[C@@H](CO)N(Cc2cccc(C(=O)O)c2)C(=O)c2ccc(-c3ccnc(N)c3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 6/20 0.40
ROCK1 Q13464 2/20 0.40
KMT2A Q03164 1/20 0.37
KDM4C Q9H3R0 2/20 0.35
KDM4A O75164 1/20 0.35
HTT P42858 1/20 0.35
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35
IDO1 P14902 2/20 0.34
TDO2 P48775 1/20 0.34
KDM5A P29375 1/20 0.34
KDM2B Q8NHM5 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25530633 0.91 ROCK2 (0.45) ROCK2ROCK1IDO1
SCHEMBL25530636 0.85 ROCK2 (0.43) ROCK2ROCK1BRD4
SCHEMBL25530811 0.81 BRD4 (0.49) ROCK2ROCK1BRD4
SCHEMBL25528651 0.81 ROCK2 (0.38) ROCK2ROCK1KMT2ABRD4
SCHEMBL25530887 0.80 KMT2A (0.39) ROCK2ROCK1KMT2AKDM4CKDM4A
SCHEMBL25528328 0.80 BRD4 (0.43) ROCK2ROCK1BRD4
SCHEMBL25529501 0.79 ROCK1 (0.47) ROCK2ROCK1KMT2AKDM4CKDM4A
SCHEMBL25528332 0.79 ROCK2 (0.38) ROCK2ROCK1PRKAG1PRKAA2PRKAB1
SCHEMBL25528333 0.78 ROCK2 (0.39) ROCK2ROCK1BRD4
SCHEMBL25529691 0.77 ROCK2 (0.40) ROCK2ROCK1IDO1TDO2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed